Health
FDA Approves Treatment for Chronic Kidney Disease – StreetInsider.com
SILVER SPRING, Md., April 30, 2021 /PRNewswire/ –Â Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the…
SILVER SPRING, Md., April 30, 2021 /PRNewswire/ – Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression. Â
“Chronic kidney disease is an important public health issue, and there is a significant unmet need for therapies that slow disease progression and improve…
-
Noosa News24 hours agoFuel tanker driver killed in horror head-on crash near Blackbutt identified as beloved father-of-two
-
General18 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Noosa News22 hours agoPalestine protesters forced into last-minute reroute
-
Business22 hours agoUp 20% in 2 days, are Codan shares a buy, hold or sell?